Stockholders approve charter amendment to limit officer liability; elect three Class II directors

PLIANT THERAPEUTICS, INC.

Amendment limiting officer liability approved with 35.2M For, 3.8M Against, 881.7K Abstain; filed June 9, 2025.
Class II directors elected: John Curnutte (34.5M For), Katharine Knobil (26.7M For), Thomas McCourt (31.6M For).
Advisory say-on-pay passed with 30.0M For, 8.9M Against, 910.9K Abstain.
Ratification of Deloitte as auditor for FY2025 approved with 50.8M For, 506K Against, 931K Abstain.
Broker non-votes totaled 12.35M shares on all proposals except auditor ratification.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

PLIANT THERAPEUTICS, INC.: Stockholders approved an amendment to the Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law, effective June 9, 2025 (effective 2025-06-09).

Change: charter amendment
Effective: 2025-06-09

Exact text from the filing

At the Annual Meeting, the stockholders of the Company approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company, as permitted by Delaware law (the “Amendment”), as further described in the Company’s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on April 23, 2025 (the “Proxy Statement”). The Amendment became effective upon the filing of a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on June 9, 2025.

View on SEC.gov

74 governance changes filed in the last 30 days. Browse all governance changes →

PLIANT THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001746473-25-000105

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.